Canesi Ex Rel. Canesi v. Wilson

730 A.2d 805, 158 N.J. 490, 1999 N.J. LEXIS 817
CourtSupreme Court of New Jersey
DecidedJune 17, 1999
StatusPublished
Cited by46 cases

This text of 730 A.2d 805 (Canesi Ex Rel. Canesi v. Wilson) is published on Counsel Stack Legal Research, covering Supreme Court of New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Canesi Ex Rel. Canesi v. Wilson, 730 A.2d 805, 158 N.J. 490, 1999 N.J. LEXIS 817 (N.J. 1999).

Opinions

The opinion of the Court was delivered by

HANDLER, J.

In this medical malpractice case, parents brought suit against two obstetricians after their child was born with the congenital defect of bilateral limb reduction. The parents’ principal allegation was that the doctors were negligent in failing to warn them that a drug prescribed for the plaintiff mother posed the specific risk of fetal limb reduction and that the prescribed drug caused this defect. They also alleged other acts of negligence, including the failure to warn of general, unspecified fetal risks posed by the prescribed drug, and to take diagnostic measures during the mother’s pregnancy that would have disclosed the presence of a fetal defect. They assert that as a result of defendants’ negligence they were deprived of their right as parents to decide whether or not to terminate the pregnancy, they would have terminated the pregnancy had they been warned, and they are entitled to the damages allowable in a wrongful birth cause of action. The doctors, focusing on the parents’ allegation that the prescribed drug caused their child’s birth defect, characterize plaintiffs’ claims as based on the doctrine of informed consent and [499]*499contend, accordingly, that they cannot be found liable because the parents cannot prove medical causation, that is, that the drug was the medical cause of the child’s congenital impairment.

In light of the contentions of the parties and the determinations of the lower courts, the basic issue that must be addressed is whether it is necessary to establish medical causation in a wrongful birth action that involves the prescription of drugs without adequate warning of the fetal risks posed by those drugs.

I

On July 1,1991, plaintiff Melissa Canesi, then twenty-nine years old, consulted defendant Dr. James A. Wilson, a specialist in obstetrics and gynecology, concerned that she might be pregnant because she had been amenorrheic for eleven days. A urinalysis yielded the same results as a home pregnancy test had: plaintiff was not pregnant. Thereafter, Dr. Wilson prescribed for plaintiff Provera, a progestational agent designed to induce menstruation. Dr. Wilson did not provide any information to plaintiff concerning the potential side effects and contraindications of the drug. At the time, the Physicians’ Desk Reference (PDR) warned that if a woman was or became pregnant while taking Provera, she should be advised that there was a risk that the fetus would suffer from congenital anomalies, including limb reduction, and a risk that she would retain a defective ovum instead of spontaneously aborting it.

Provera did not succeed in inducing menstruation and, on July 15, Dr. Wilson gave plaintiff a blood serum test to determine if she was pregnant. This time, the test was positive. Upon learning that she was pregnant with twins, plaintiff asked Dr. Wilson if her ingestion of Provera would have a deleterious impact on the fetuses or the course of her pregnancy. Dr. Wilson told plaintiff not to worry.

Because Dr. Wilson was not a participating physician in plaintiffs health insurance plan, she needed to look elsewhere for pregnancy care. On July 25, she saw Dr. Ronald Loewe for the first time and informed him both of her pregnancy and of the fact [500]*500that she had taken Provera. Dr. Loewe told her that she should not be concerned that she had taken the drug.

Plaintiffs pregnancy was not without incident. She began spotting, one of the fetal twins died, and an amniocentesis revealed excessive amniotic fluid, an indication that the remaining fetus might be suffering from an abnormality. .On March 18, 1992, plaintiff gave birth to a boy, Brandon, who had the congenital impairment of bilateral limb reduction.

Plaintiff, together with her husband Sebastian, sued Drs. Wilson and Loewe, alleging that Dr. Wilson was negligent for failing to diagnose her pregnancy in a timely manner, and that both doctors were negligent for failing to inform her of the effect her ingestion of Provera would have on her fetus and for “otherwise” negligently caring for and treating her. Plaintiff claimed that had she known of the risk of congenital defects generally, or limb reduction specifically, that Provera posed to her remaining fetus, or had she been told that she was at an increased risk of retaining a defective ovum, she would have terminated her pregnancy. Being kept ignorant of these risks, she asserted, deprived her of the personal choice of determining whether or not to terminate her pregnancy. The complaint also included a claim brought on behalf of Brandon. That claim alleged that Provera caused his bilateral limb reduction and that defendants were negligent in prescribing the drug to his mother without warning of this risk.

Defendants moved for summary judgment. They pointed out that not only did plaintiffs fail to present any expert testimony that Provera caused fetal limb reduction, but the latest edition of the PDR no longer contained a warning that Provera was even associated with this defect.1 Construing the cause of action essentially to be one involving the lack of informed consent, the defendants contended that, because plaintiffs could not prove medical causation, i.e., that Provera had actually caused Brandon’s [501]*501limb reduction, defendants, as a matter of law, could not be found liable.

The trial court granted defendants’ motion, noting that a plaintiff who alleges that her physician’s malpractice consists of a failure to disclose material risks of a prescribed drug must prove that the drug in fact caused the harm that materialized. The Appellate Division affirmed. 295 N.J.Super. 354, 685 A.2d 49 (1996). The court determined that even if plaintiffs’ claim was denominated a wrongful birth action based on the lost opportunity to terminate the pregnancy, plaintiffs still “must establish that the taking of Provera caused Brandon’s limb reduction abnormalities.” Id. at 362, 685 A.2d 49.

The Court granted plaintiffs’ petition for certification. 149 N.J. 139, 693 A.2d 109 (1997).

II

A.

A wrongful birth cause of action is predicated on a woman’s right to determine for herself whether or not to continue or terminate her pregnancy. Persons “have a right of their own either to accept or reject a parental relationship, and the deprivation of that right by the negligent misconduct of another creates a cause of action in the parents.” Schroeder v. Perkel, 87 N.J. 53, 66, 432 A.2d 834 (1981). The right protects a distinctively personal interest. See Hummel v. Reiss, 129 N.J. 118, 136, 608 A.2d 1341 (1992) (Handler, J., dissenting) (noting that because decision to terminate pregnancy “involve[s] profound moral and personal issues,” it is one that “only [the patient] could make”).

The violation of the interest in self-determination that undergirds a wrongful birth cause of action consists of the parents’ lost opportunity to make the personal decision of whether or not to give birth to a child who might have birth defects. Schroeder, supra, 87 N.J. at 66, 432 A.2d 834. The claim in a wrongful birth action can arise when a physician fails to provide adequate genetic counselling, see id. at 63, 432 A.2d 834

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Planned Parenthood v. State
2025 MT 120 (Montana Supreme Court, 2025)
In the Matter of Hartz Mountain Industries, Etc.
New Jersey Superior Court App Division, 2024
State of New Jersey v. Juan A. Lema
New Jersey Superior Court App Division, 2024
Acord v. Porter
475 P.3d 665 (Court of Appeals of Kansas, 2020)
Alan Andersen v. Sohit Khanna and Iowa Heart Center
913 N.W.2d 526 (Supreme Court of Iowa, 2018)
Abigail Ginsberg v. Quest Diagnostics, Incorporated (076288)
147 A.3d 434 (Supreme Court of New Jersey, 2016)
Leonides Velazquez v. City of Camden and Officer Alexis Ramos
146 A.3d 681 (New Jersey Superior Court App Division, 2016)
Abigail Ginsberg v. Quest Diagnostics, Inc.
117 A.3d 200 (New Jersey Superior Court App Division, 2015)
Ike J. White, III v. David A. Beeks, M.D.
Court of Appeals of Tennessee, 2013
Kaye v. Rosefielde
75 A.3d 1168 (New Jersey Superior Court App Division, 2013)
Peckham v. Idaho State Board of Dentistry
303 P.3d 205 (Idaho Supreme Court, 2013)
Rowe v. Mazel Thirty, LLC
34 A.3d 1248 (Supreme Court of New Jersey, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
730 A.2d 805, 158 N.J. 490, 1999 N.J. LEXIS 817, Counsel Stack Legal Research, https://law.counselstack.com/opinion/canesi-ex-rel-canesi-v-wilson-nj-1999.